Skip to content

A prospective single-center clinical trial of radiofrequency ablation maze procedure in surgical treatment of rheumatic heart valve disease

A prospective single-center clinical trial of radiofrequency ablation maze procedure in surgical treatment of rheumatic heart valve disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-07003039
Enrollment
Unknown
Registered
2007-01-01
Start date
2006-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Cox IV group:valve replcement plus COX IV operation
Cox IV plus ganglion plexus abltion group:Cox IV plus ganglion plexus abltion
no-Maze group:only valve replcement

Sponsors

General Hospital of Shenyang Millitary Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: rheumatic heart valve disease with atrial fibrillation

Exclusion criteria

Exclusion criteria: Reoperation, combined with coronary heart disease (CHD), emergency surgery

Design outcomes

Primary

MeasureTime frame
free of atrial fibrillation;

Secondary

MeasureTime frame
mortality;risk factor;

Countries

China

Contacts

Public ContactWang huishan
huishanwang@hotmail.com+86 024 28897381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026